Recombinant IL33 (Etokimab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL33 (Etokimab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL33 (Etokimab Biosimilar) in samples from Human.
Catalog No. ABIN7488200
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL33 (Etokimab Biosimilar) antibody (ABIN7488200)
Target
IL33 (Etokimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL33 (Etokimab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Etokimab Biosimilar - Anti-IL33 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL33 (Etokimab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
ANB020
Etokimab, previously known as ANB020, is an antibody that inhibits the activity of IL-33, a pro-inflammatory cytokine that multiple studies have indicated is a central mediator of atopic diseases. -
CAS-No
- 2022981-44-6
Target
-
You are here:
